Carotid Artery Stenosis Clinical Trial
Official title:
Observational Multicentre Clinical Trial for Validation of Taxinomisis, New Stratification Tool for Stroke Risk in Patients With Carotid Disease
Introduction: Taxinomisis trial is part of the Taxinomisis project. The concept of the Taxinomisis project is to stratify carotid artery disease relying on new modern data corresponding to contemporary patients based on information from longitudinal studies. Taxinomisis trial will validate this tool and adjust such stratification. Initial step of the project is characterization of symptomatic and asymptomatic carotid atherosclerotic plaque lesions, identification of risk and susceptibility factors through the exploitation of longitudinal cohort data and multiomics and disintegration of carotid artery disease phenotypes into endotypes through joint modeling of multipleomics data sets and systems medicine approaches. Finally such stratification model will be validated and adjusted in the Taxinomisis clinical trial.
Aim of the trial is to validate TAXINOMISIS system for risk stratification of carotid artery
stenotic disease. Primary endpoints are stroke, transitory ischemic attack or retinal symptom
while secondary endpoints are MRI silent brain lesions and carotid plaque progression.
Patient with moderate to severe extra-cranial, both asymptomatic and symptomatic, carotid
artery stenosis will be enrolled in the prospective observational multi-center trial in five
European (Athens, Barcelona, Belgrade, Genoa, Munich and Utrecht) vascular centers. Inclusion
will last from 31.3.2018 - 01.06.2019. Patients with short life expectancy, high potential of
stroke from other cause or patients with complex and tandem carotid lesions will be excluded
from the trial.
Included patients will be examined clinically, basic laboratory exam will be performed and
part of blood specimen will be stored and assessed later. Carotid plaque will be analysed by
means of duplex and MRI image while brain lesions will be detected on brain MRI.
Treatment strategy will be dependent on guidelines of good clinical practice and let
independently to institutional multidisciplinary panelist board. In patients treated with
carotid endarterectomy (CEA) carotid plaque will be stored and assessed for future analysis.
In respect to allocated therapy patients will follow different follow up protocols.
Intervention group: Patients undergoing intervention CEA or carotid artery stenting (CAS),
will be followed by clinical examination and carotid duplex on 12, 24 and 36 month. If there
is coexisting contralateral carotid stenosis greater than 50% and not requiring
interventional treatment (CEA or CAS), patient should cross in optimal medical therapy group.
Optimal medical therapy group: Patients not subjected to intervention (or in whom one carotid
has been treated with CAS or CEA and contra-lateral stenosis is greater than 50%) will be
followed with carotid duplex (at 12, 24 and 36 months) and MRI imaging of carotid tree from
aortic arch up to the circle of Willis after 12 and 36 months.
Trial plans to recruit 270 patients distributed in participating centers based on individual
capabilities of each center. The diagnostic performance of the new risk model, and its
accuracy to discriminate high versus low risk cases for cerebrovascular complications from
carotid artery disease will be evaluated using Receiver Operating Characteristic (ROC) curve
analysis. The accuracy (discriminated ability) of the model will be assessed by measuring the
Area under the ROC curve (AUC). An AUC 0.80 and 90% CI, for the sensitivity of prediction
model of 80% with marginal error of 10%, will be targeted.
Trial will terminate after finalizing 36 months of follow up for included patients at June
2022.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03931161 -
Effect of Evolocumab on Carotid Plaque Composition in Asymptomatic Carotid Artery Stenosis (EVOCAR-1)
|
Phase 4 | |
| Recruiting |
NCT03353103 -
Imaging of Unstable Carotid Plaque in Patient Referred to Endarterectomy
|
Phase 2 | |
| Completed |
NCT03996148 -
Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques
|
Phase 4 | |
| Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
| Completed |
NCT00318851 -
Carotid Artery Stenting With Protection Registry
|
Phase 3 | |
| Completed |
NCT00597974 -
Neurological Outcome With Carotid Artery Stenting
|
N/A | |
| Active, not recruiting |
NCT05293067 -
Troponin In Carotid Revascularization
|
||
| Completed |
NCT03133429 -
Clinical Study to Evaluate the Safety and Effectiveness of MER® Stents in Carotid Revascularisation.
|
N/A | |
| Recruiting |
NCT01440036 -
The Correlation Between the Enzyme Paraoxigenase 1 (PON1) to Carotid Artery Atheromatous Plaque
|
N/A | |
| Completed |
NCT00417963 -
ViVEXX Carotid Revascularization Trial (VIVA)
|
Phase 3 | |
| Completed |
NCT00177346 -
A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection
|
N/A | |
| Recruiting |
NCT05574972 -
Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis（Timing Trial）
|
N/A | |
| Recruiting |
NCT02476396 -
Structural Stability of Carotid Plaque and Symptomatology
|
||
| Completed |
NCT05451485 -
VFI in Healthy Vessels
|
||
| Recruiting |
NCT06033963 -
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Carotid Artery Stenosis Receiving Carotid EndArterectomy
|
N/A | |
| Not yet recruiting |
NCT02224209 -
Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis
|
Phase 4 | |
| Completed |
NCT02006095 -
Neuroimaging Correlates of Memory Decline Following Carotid Interventions
|
||
| Terminated |
NCT01236508 -
Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease
|
Phase 4 | |
| Recruiting |
NCT05126238 -
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
|
Phase 3 | |
| Recruiting |
NCT06170580 -
Improved Image Quality for Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound FLOW Imaging
|